Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Joy Kelly — AKESIS PHARMACEUTICALS, INC. insider: 1 transactions · InsiderLens

Home / Insiders / Joy Kelly

Joy Kelly

VP, Business Development at AKESIS PHARMACEUTICALS, INC. · on record since Jan 28, 2005

Insider trading activity of Joy Kelly

Transactions on record: 1; since Jan 5, 2006

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Jan 5, 2006

Figures computed from official regulatory filings — methodology.

Companies where Joy Kelly has traded

AKESIS PHARMACEUTICALS, INC.1 tx · Jan 5, 2006

Track record of Joy Kelly

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Joy Kelly

Co-insiders of Joy Kelly

Avalon Ventures VII L PAKESIS PHARMACEUTICALS, INC.
Fine Floree RAKESIS PHARMACEUTICALS, INC.
Fine Stuart AAKESIS PHARMACEUTICALS, INC.
Hendrick John TAKESIS PHARMACEUTICALS, INC.
Keeling Gary RAKESIS PHARMACEUTICALS, INC.
Kinsella Kevin JAKESIS PHARMACEUTICALS, INC.
LeBel CarlAKESIS PHARMACEUTICALS, INC.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Lichter JayAKESIS PHARMACEUTICALS, INC.

SAYER KEVIN RAKESIS PHARMACEUTICALS, INC.

SFLL Fine Family Investments Partnership, L.P.AKESIS PHARMACEUTICALS, INC.

STEEL JOHN F IVAKESIS PHARMACEUTICALS, INC.

Wilson Edward BAKESIS PHARMACEUTICALS, INC.

Company	Filed	Type	Qty	Price	Value · USD	Src
AKESIS PHARMACEUTICALS, INC.	Jan 5, 2006	AwardD	200,000	0.00	$0	SEC